Healthcare -
Medical - Devices - NASDAQ - US
$ 12.13
1.39 %
$ 397 M
Market Cap
-12.57
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
NeuroPace, Inc.
| Revenue | 79.9 M |
| Cost Of Revenue | 20.8 M |
| Gross Profit | 59.1 M |
| Operating Expenses | 80.8 M |
| Operating Income | -21.7 M |
| Other Expenses | 5.47 M |
| Net Income | -27.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 79.9 | 65.4 | 45.5 | 45.2 | 41.1 | 37.0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 20.8 | 17.3 | 13.0 | 11.7 | 10.9 | 10.5 |
| Gross Profit | 59.1 | 48.1 | 32.5 | 33.4 | 30.3 | 26.5 |
| OPERATING INCOME | ||||||
| Operating Expenses | 80.8 | 75.3 | 73.3 | 57.2 | 43.3 | 48.5 |
| Selling, General and Administrative Expenses | 57.1 | 54.5 | 51.3 | 39.0 | 27.6 | 30.2 |
| Research and Development Expenses | 23.7 | 20.8 | 21.9 | 18.2 | 15.7 | 18.3 |
| Operating Income | (21.7) | (27.2) | (40.8) | (23.7) | (13.1) | (22.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 8.8 | 8.5 | 7.5 | 7.4 | 11.5 | 9.5 |
| Total Other Income | (5.5) | (5.8) | (6.3) | (12.3) | (11.2) | (7.9) |
| Pre-Tax Income | (27.1) | (33.0) | (47.1) | (36.1) | (24.3) | (30.0) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | 6.3 | 2.0 | 11.7 | 10.8 |
| Net Income | (27.1) | (33.0) | (53.4) | (38.1) | (36.0) | (40.7) |
| EPS | 0.93 | 1.27 | 2.17 | 1.56 | 1.51 | 1.71 |